N. Throuvalas

1.1k total citations
27 papers, 837 citations indexed

About

N. Throuvalas is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, N. Throuvalas has authored 27 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in N. Throuvalas's work include Effects of Radiation Exposure (8 papers), Advanced Radiotherapy Techniques (7 papers) and Glioma Diagnosis and Treatment (6 papers). N. Throuvalas is often cited by papers focused on Effects of Radiation Exposure (8 papers), Advanced Radiotherapy Techniques (7 papers) and Glioma Diagnosis and Treatment (6 papers). N. Throuvalas collaborates with scholars based in Greece, United States and Venezuela. N. Throuvalas's co-authors include D. Antonadou, M. Synodinou, P. Karageorgis, N. Coliarakis, M. Paraskevaidis, George E. Sarris, Maria Ausiliatrice Puglisi, I. Economou, N. Malamos and H. Athanassiou and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

N. Throuvalas

24 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Throuvalas Greece	9	580	331	284	194	167	27	837
N. Coliarakis Greece	5	427 0.7×	270 0.8×	172 0.6×	181 0.9×	40 0.2×	8	549
Dirk K.M. De Ruysscher Netherlands	15	385 0.7×	330 1.0×	150 0.5×	58 0.3×	36 0.2×	46	701
Hsing‐Lung Chao Taiwan	17	283 0.5×	200 0.6×	106 0.4×	40 0.2×	209 1.3×	36	764
Tuija Wigren Finland	12	235 0.4×	142 0.4×	117 0.4×	27 0.1×	154 0.9×	20	502
Chung K.K. Lee United States	13	197 0.3×	113 0.3×	109 0.4×	64 0.3×	23 0.1×	20	519
Brian Chon United States	14	187 0.3×	74 0.2×	205 0.7×	150 0.8×	18 0.1×	36	797
Jacek Fijuth Poland	11	208 0.4×	175 0.5×	77 0.3×	22 0.1×	57 0.3×	85	458
Cem Parlak Türkiye	11	156 0.3×	148 0.4×	150 0.5×	49 0.3×	21 0.1×	30	398
Ayşe Nur Demiral Türkiye	13	197 0.3×	141 0.4×	44 0.2×	33 0.2×	101 0.6×	31	402
Min Kyu Kang South Korea	13	127 0.2×	111 0.3×	112 0.4×	15 0.1×	62 0.4×	54	484

Countries citing papers authored by N. Throuvalas

Since Specialization

Citations

This map shows the geographic impact of N. Throuvalas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Throuvalas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Throuvalas more than expected).

Fields of papers citing papers by N. Throuvalas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Throuvalas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Throuvalas. The network helps show where N. Throuvalas may publish in the future.

Co-authorship network of co-authors of N. Throuvalas

This figure shows the co-authorship network connecting the top 25 collaborators of N. Throuvalas. A scholar is included among the top collaborators of N. Throuvalas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Throuvalas. N. Throuvalas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Throuvalas, N., D. Antonadou, Robert S. Lavey, Mourad Boufi, & N. Malamos. (2004). Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors. International Journal of Radiation Oncology*Biology*Physics. 60(1). S300–S300. 4 indexed citations

Throuvalas, N., et al.. (2004). Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors. International Journal of Radiation Oncology*Biology*Physics. 60. S300–S300. 1 indexed citations

Athanassiou, H., D. Antonadou, N. Coliarakis, et al.. (2003). Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial. International Journal of Radiation Oncology*Biology*Physics. 56(4). 1154–1160. 79 indexed citations

Antonadou, D., et al.. (2003). Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer. Seminars in Oncology. 30(6 Suppl 18). 2–9. 24 indexed citations

Antonadou, D., N. Coliarakis, M. Paraskevaidis, et al.. (2003). 777 A multi-institutional trial comparing survival of patients with brain metastases from lung cancer treated with temozolomide plus radiotherapy versus radiotherapy alone. European Journal of Cancer Supplements. 1(5). S234–S234. 3 indexed citations

Antonadou, D., H. Athanassiou, George E. Sarris, et al.. (2003). 1087 Randomized phase III trial of chemoradiation treatment amifostine in patients with colorectal cancer. European Journal of Cancer Supplements. 1(5). S325–S325. 1 indexed citations

Antonadou, D., et al.. (2003). 926 Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors. European Journal of Cancer Supplements. 1(5). S279–S279. 1 indexed citations

Antonadou, D., et al.. (2002). Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. International Journal of Radiation Oncology*Biology*Physics. 52(3). 739–747. 183 indexed citations

Antonadou, D., N. Coliarakis, M. Paraskevaidis, et al.. (2002). Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. a phase III study. International Journal of Radiation Oncology*Biology*Physics. 54(2). 93–94. 37 indexed citations

10.

Antonadou, D., M. Paraskevaidis, George E. Sarris, et al.. (2002). Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain Metastases. Journal of Clinical Oncology. 20(17). 3644–3650. 254 indexed citations

11.

Antonadou, D., et al.. (2001). Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer. International Journal of Radiation Oncology*Biology*Physics. 51(4). 915–922. 154 indexed citations

12.

Antonadou, D., et al.. (2001). Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. European Journal of Cancer. 37. S358–S358. 2 indexed citations

13.

Antonadou, D., et al.. (2001). Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study. European Journal of Cancer. 37. S144–S144. 38 indexed citations

14.

Paraskevaidis, Evangelos, et al.. (2000). A phase III randomized trial of synchronous radiotherapy with temozolomide in brain metastases. International Journal of Radiation Oncology*Biology*Physics. 48(3). 114–114. 1 indexed citations

15.

Antonadou, D., et al.. (1999). Effect of amifostine on toxicities associated with induction chemotherapy and radiotherapy for head and neck and lung cancer. European Journal of Cancer. 35. S377–S377.

16.

Antonadou, D., et al.. (1998). The prophylactic use of amifostine in the prevention of chemoradiation induced mucositis and xerostomia in head and neck cancer. International Journal of Radiation Oncology*Biology*Physics. 42(1). 224–224. 8 indexed citations

17.

Antonadou, D., M. Synodinou, Panagiotis Iliopoulos, Michail Katsoulis, & N. Throuvalas. (1995). 1190 Combined radiotherapy and immunotherapy in advanced stages of cancer of the uterine cervix. European Journal of Cancer. 31. S248–S248. 1 indexed citations

18.

Throuvalas, N., et al.. (1995). 431 Evaluation of the efficacy and safety of GM–CSF in the phophylaxis of mucositis in patients with head and neck cancer treated with RT. European Journal of Cancer. 31. S93–S93. 7 indexed citations

19.

Makrigiorgos, G. Mike, et al.. (1990). . Physics in Medicine and Biology. 35(1). 139–145. 1 indexed citations

20.

Karageorgis, P., et al.. (1982). Contribution of the hyperdynamic radiotherapy in the treatment of the nasopharynx tumors.. PubMed. 158(3). 156–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact